A number of Listed Companies in Shanghai and Shenzhen issued important announcements on December 29. The following is a summary of good news:
Xinyaqiang Silicon Chemistry Co.Ltd(603155) : the product hexamethyldisilazane is recognized as the single champion product in the manufacturing industry
Xinyaqiang Silicon Chemistry Co.Ltd(603155) (603155) announced on December 29 that recently, the company received a notice issued by Jiangsu Provincial Department of industry and information technology that the company’s core product hexamethyldisilazane was recognized as the single champion product of manufacturing industry (the Sixth Batch) by the Ministry of industry and information technology and China Industrial Economic Federation.
Henan Hengxing Science & Technology Co.Ltd(002132) : the project with an annual output of 120000 tons of high-performance silicone polymer meets the trial production conditions
Henan Hengxing Science & Technology Co.Ltd(002132) (002132) on December 29, it was announced that the trial production scheme of the “120000 T / a high-performance silicone polymer project” of Xingxing chemical, the holding subsidiary of the company, was reviewed and approved by the expert group. It has the conditions for commissioning and can officially enter the trial production stage.
Dirui Industrial Co.Ltd(300396) : the IPO of Zhishan biological gem was accepted
Dirui Industrial Co.Ltd(300396) (300396) announced on December 29 that the application of Xiamen Zhishan Biotechnology Co., Ltd. (hereinafter referred to as “Zhishan biotechnology”) for initial public offering and listing on the gem was accepted by Shenzhen Stock Exchange. Up to now, the company holds Jinyu Bio-Technology Co.Ltd(600201) 6652700 shares of Zhishan, accounting for 14.78% of its total share capital.
Boya Bio-Pharmaceutical Group Co.Ltd(300294) : the application for clinical trial of intravenous human immunoglobulin (10%) was approved
Boya Bio-Pharmaceutical Group Co.Ltd(300294) (300294) announced on December 29 that the application for clinical trial of intravenous human immunoglobulin (10%) of the company’s products has been approved by the State Food and drug administration. Intravenous injection of human immunoglobulin (10%) is suitable for the treatment of primary immunoglobulin G deficiency. At present, there is no Chinese product on the market.
Changchun Zhiyuan New Energy Equipment Co.Ltd(300985) : it is proposed to acquire 49% equity of Zhiyou new energy to achieve wholly-owned holding
Changchun Zhiyuan New Energy Equipment Co.Ltd(300985) (300985) announced on December 29 that the company plans to purchase 34% equity of Zhiyou (Changchun) new energy auto parts manufacturing Co., Ltd. (hereinafter referred to as “Zhiyou new energy”) held by Sanyou company and 15% equity of Zhiyou new energy held by Huicheng brothers at the price of 36.9133 million yuan. After the completion of the transaction, Zhiyou new energy became a wholly-owned subsidiary of the company. Zhiyou new energy’s main products are the frame and head of on-board LNG gas supply system. It is a localized supporting supplier of Changchun Zhiyuan New Energy Equipment Co.Ltd(300985) .
Yibin Tianyuan Group Co.Ltd(002386) : the expansion project of titanium dioxide by chlorination has entered normal production and operation
Yibin Tianyuan Group Co.Ltd(002386) (002386) announced on December 29 that the company’s annual output of 50000 tons of chlorinated titanium dioxide expansion project has met the full production conditions after preliminary commissioning and trial production. At present, it has entered normal production and operation. The completion and operation of the project will further promote the transformation of the company from basic Shanghai Chlor-Alkali Chemical Co.Ltd(600618) to new chemical materials industry. At the same time, it will expand the production scale of chlorinated titanium dioxide, which will have a positive impact on the company’s future business performance.
Beijing Zhong Ke San Huan High-Tech Co.Ltd(000970) : the net profit in 2021 is expected to increase by 155.18% – 278.9%
Beijing Zhong Ke San Huan High-Tech Co.Ltd(000970) (000970) disclosed the performance forecast for 2021 on December 29. It is estimated that the net profit in 2021 will be RMB 330 million-490 million, with a year-on-year increase of 155.18% – 278.9%. During the reporting period, the company’s orders increased significantly.
Beijing Beilu Pharmaceutical Co.Ltd(300016) : capital health industry fund
Beijing Beilu Pharmaceutical Co.Ltd(300016) (300016) announced on December 29 that the company, as a limited partner, plans to invest 50 million yuan in Huagai Lisheng equity investment partnership (limited partnership) in Ningbo Meishan free trade port area (hereinafter referred to as “Huagai Lisheng”). Huagai Lisheng aims to invest in capital health industry (Beijing) Fund (limited partnership).
China-Singapore Suzhou Industrial Park Development Group Co.Ltd(601512) : the company and its subsidiaries intend to invest no more than 160 million yuan in the fund
China-Singapore Suzhou Industrial Park Development Group Co.Ltd(601512) (601512) announced on December 29 that the company and its subsidiaries intend to subscribe a capital contribution of no more than 100 million yuan to participate in the investment in Suzhou Chuanliu changeucalyptus new material venture capital partnership (limited partnership); The company plans to subscribe a capital contribution of no more than 60 million yuan to participate in the investment in Suzhou daotong Tenghui venture capital partnership (limited partnership).
Sunyard Technology Co.Ltd(600571) : it is proposed to invest 50 million yuan in Shunxin investment
Sunyard Technology Co.Ltd(600571) (600571) it was announced on December 29 that the company plans to invest 50 million yuan in Gongqingcheng Shunxin investment partnership (limited partnership) (hereinafter referred to as “Shunxin investment”). The total subscribed capital contribution of Shunxin investment is 151 million yuan, and the company holds 33.11% of it. Shun core investment mainly invests in high-quality common shares of unlisted enterprises upstream and downstream of the industrial chain of the integrated circuit industry and supporting related industries.
Milkyway Chemical Supply Chain Service Co.Ltd(603713) : sign the wind turbine transportation service project contract with Ming Yang Smart Energy Group Limited(601615)
Milkyway Chemical Supply Chain Service Co.Ltd(603713) (603713) announced on December 29 that it signed the contract for wind turbine transportation service project of WTO wind farm in jin’ou, Vietnam with Ming Yang Smart Energy Group Limited(601615) (601615). During the term of the contract, Ming Yang Smart Energy Group Limited(601615) entrusted the company to provide wind turbine transportation service of the wind farm. The estimated total price of transportation and other supporting services under the contract is about 148 million yuan.
Hubei Three Gorges Tourism Group Co.Ltd(002627) : signed a strategic cooperation agreement with Three Gorges capital
Hubei Three Gorges Tourism Group Co.Ltd(002627) (002627) it was announced on December 29 that the company, the controlling shareholder Yichang jiaolv and the company’s affiliated legal person Three Gorges capital jointly signed the strategic cooperation agreement. The three parties will promote the optimization and integration of tourism resources around the Yangtze River economic belt; Jointly explore the mode of power exchange and electric ship leasing, and replicate and promote ship electrification and shore power projects; Cooperate in the construction and operation of Yichang charging pile and vehicle electrification; Jointly expand the distributed photovoltaic project in Yichang.
China Yangtze Power Co.Ltd(600900) : sign the power purchase and sales contract of Xiluodu right bank power station from 2021 to 2025
China Yangtze Power Co.Ltd(600900) (600900) announced on December 29 that Yongshan Xiluodu power plant of Three Gorges Jinsha River Chuanyun Hydropower Development Co., Ltd., as the seller, signed the power purchase and sales contract for Xiluodu right bank power station from 2021 to 2025 with the power purchaser, China Southern Power Grid Co., Ltd. EHV transmission company. The signing of the contract is the basis for the power consumption of Xiluodu right bank power station, provides a guarantee for the smooth power consumption from 2021 to 2025, and is expected to have a positive impact on the operating performance.
Xinjiang Beiken Energy Engineering Co.Ltd(002828) : sign a service contract for 500 million yuan shale gas drilling and testing integration project
Xinjiang Beiken Energy Engineering Co.Ltd(002828) (002828) announced on December 29 that the company and the development division of Petrochina Company Limited(601857) southwest oil and gas field branch signed a shale gas drilling and testing integration engineering service contract, with a tentative total contract amount of RMB 500 million, accounting for 53.43% of the company’s operating revenue in 2020. The performance period of the contract is from the date of signing the contract to December 31, 2023.
Jangho Group Co.Ltd(601886) : winning the bid for the facade project of plot 58-01 in Zhangjiang Central District
Jangho Group Co.Ltd(601886) (601886) announced on December 29 that Shanghai Jianghe curtain wall system engineering Co., Ltd., a wholly-owned subsidiary, recently received the letter of acceptance for the facade project of plot 58-01 in central Zhangjiang sent by Shanghai Haoji Zhangxin Construction Development Co., Ltd., with a bid winning amount of 418 million yuan, accounting for about 2.32% of the company’s operating revenue in 2020. The project is located in Pudong New Area, Shanghai. The total construction period is expected to be 732 days. After completion, it will become one of the landmark business complexes in the region.
Wiscom System Co.Ltd(002090) : recently won the bid of 33.8452 million yuan for the State Grid and China Southern Power Grid Project
Wiscom System Co.Ltd(002090) (002090) announced on December 29 that recently, the company won the relevant projects of State Grid Co., Ltd. and China Southern Power Grid Co., Ltd., with a cumulative winning amount of 33.8452 million yuan, accounting for 1.82% of the company’s total operating revenue in 2020. The performance of the project will have a positive impact on the company’s operating performance.
Tonghua Golden-Horse Pharmaceutical Industey Co.Ltd(000766) : the main products of the subsidiary won the bid and were purchased by the inter provincial alliance of Chinese patent medicine
Tonghua Golden-Horse Pharmaceutical Industey Co.Ltd(000766) (000766) it was announced on December 29 that Xiaojin pill, the leading product of Yongkang pharmaceutical, a wholly-owned subsidiary, won the bid for centralized volume procurement of inter provincial alliance of Chinese patent medicine. The total sales of this variety in 2020 was 149 million yuan, accounting for 13.42% of the company’s operating revenue.
Jinguan Electric Co.Ltd(688517) : the product won the bid for the procurement project of supporting energy storage equipment for roof photovoltaic power station
Jinguan Electric Co.Ltd(688517) (688517) it was announced on December 29 that Nanyang Jinguan intelligent switch Co., Ltd., a wholly-owned subsidiary of the company, won the bid for the first bid section of “procurement project of supporting energy storage equipment for roof photovoltaic power station of standardized plant in industrial agglomeration area of Neixiang County”, with a bid winning amount of 8.88 million yuan, accounting for 1.68% of the company’s business revenue in 2020.
